medigraphic.com
ISSN 1817-5996 (Electronic)

2011, Number 18

<< Back Next >>

Rev Cub de Reu 2011; 13 (18)

ActivAR. Software para calcular la actividad clínica en pacientes con Artritis Reumatoide

Acosta HRR, García EA, Fernández QR, Barrios SM

Language: Spanish
References: 15
Page:
PDF size: 83.57 Kb.


ABSTRACT

No abstract.


REFERENCES

  1. Batlle-Gualda E. ¿Cómo se debe evaluar la artritis reumatoide? Rev Esp Reumatol 2000; 27:250-5.

  2. Tugwell P, Boers M, Baker P, Wells G, Snider J. Endpoints in rheumatoid arthritis. J Rheumatol 1994;21(Suppl):2-8.

  3. Van der Heide A, Jacobs JWG, Schenk Y, Bijlsma JWJ. Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis. J Rheumatol 1994; 21:2195-9.

  4. Goldsmith CH, Boers M, Bombardier C, Tugwell P, for the OMERACT Committee. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patients and trial profiles. J Rheumatol 1993; 20:561-5.

  5. Muirden KD. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 527.

  6. Van Riel PLCM. Provisional guidelines for measuring disease activity in clinical trials on rheumatoid artritis. Br J Rheumatol 1992; 31:793-6.

  7. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36:729- 40.

  8. Wolfe F, Lassere M, van der Heijde D, Stucki G, Suárez- Almanzor M, Pincus T, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999; 26:484-9.

  9. Silman A, Symmons D. Reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1992; 26:481-3.

  10. Batlle-Gualda E, Bernabeu P, Santos G, Pascual E. Methods of clinical evaluation of rheumatoid arthritis. Rev Clin Esp 2000; 200:32-8.

  11. Prevoo MLL, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte BA, van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 1995; 38:44-8.

  12. Boers M, Tugwell P. The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials. J Rheumatol 1993; 20:568-74.

  13. Alejandro Balsa, Virginia Villaverde y Emilio Martín-Mola. Índices de actividad y mejoría en la artritis reumatoide. Rev Esp Reumatol 2002; (Suppl), Vol. 1, No. 1: 4 – 8.

  14. Acosta Hernández R, Fernández Quintero R. ¿Debemos usar un índice para medir la actividad de la Artritis Reumatoide en la Consulta Diaria? Revista Cubana de Reumatología 2003; Vol. No. 5, No. 3, 4: 63-64.

  15. Van Gestel AM, Prevoo MLL, Van’t Hof MA, Van Rijswijk MH, Van de Putte LBA, Van Riel PLCM. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996; 39:34-40.




2020     |     www.medigraphic.com